The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
about
EGFR regulates the side population in head and neck squamous cell carcinoma.Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesIMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cellsImmunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interactionViable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.Molecular therapy of head and neck cancer.A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancerInteraction of antibodies with ErbB receptor extracellular regions.Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10.A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.
P2860
Q33236681-82F4BDA6-D5C2-4BA8-AD3D-7CA223FCF61DQ33822560-FB25A29D-F088-4FF7-8F83-03C2170AEB52Q34451934-5A6AEC29-2132-4470-930B-47A9CE098347Q34569071-FA6ABBEA-E1CE-4FBC-B90C-CC0AB7D38BAFQ35214496-6BD6F0DA-8D1D-4EE0-8D26-BDAFC81EA44BQ35623056-704210DB-15D0-4B87-AF99-AF3C8D56F8E8Q35975727-86BB52A9-249E-46C1-A2C8-62E5843D6170Q35998450-02C7521B-5A2E-42E0-84D9-74CC736DE04AQ36078112-04600F40-9CD1-4E7D-8184-B89656487129Q36079584-E7A18C8A-0E9C-4DC0-A3FD-DEA8498DC837Q36134525-47213AAA-1EF8-4FA9-ACEF-928E60D329E5Q37320814-65AC42A5-FC72-427C-A669-8CEC485818A0Q38835146-7DCCAA09-59DE-42ED-A511-D0A6D164DBD9Q39399928-975398FB-5BA1-432C-8430-84854EE07A56Q39885205-B34B68EE-0A7E-4ED2-BF82-75AA264DA5F2Q41065499-6B671030-3A9E-42C0-AF90-411004A5E155Q42497044-083EAE3F-35E7-426C-BCA7-C5B0AF75879DQ55004536-2FDAA84B-E9A7-4418-A435-3389F3031DA4
P2860
The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@ast
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@en
type
label
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@ast
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@en
prefLabel
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@ast
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@en
P2093
P2860
P356
P1476
The human EGF receptor as a ta ...... e breast carcinoma MDA-MB 468.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.48
P407
P577
1993-02-01T00:00:00Z
P5875
P6179
1037345733